Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f52c68e4149a6c462b850d4e7cc2b2f9 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4808 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2077 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-542 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-366 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-44 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5084 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2054 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-60 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-60 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-44 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-366 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-40 |
filingDate |
2006-10-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2012-06-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f971897208bbcb98336591ae90611eba http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_37f4bb417f55d4c5baef84f81cf40aea http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_21fd3f0f3fd3c8f8c80935ce93656037 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0799ecbcd52c78a480b79343893e2b95 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a781d63a27aefb54062fa776d704d592 |
publicationDate |
2012-06-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
EP-1937253-B1 |
titleOfInvention |
Combined preparation of o-acetylsalicylic acid salts |
abstract |
The invention relates to a fixed combination of o-acetylsalicylic acid salts with basic aminoacid in the form of a component A and an HMG-CoA-reductase inhibitor in the form of a component B, to a drug containing said combination and to a method for the production thereof. |
priorityDate |
2005-10-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |